EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors

Mater Mahnashi, Mohammed Merae Alshahrani, Amer Al Ali, Abdulaziz Asiri, Mahrous A Abou-Salim

Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2023 · 38 (1)

DOI: 10.1080/14756366.2023.2203879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 20.04.2023. Verfasst von Mater Mahnashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Folic Acid Antagonists, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Najran University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsFolic Acid AntagonistsNeoplasmsHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorPyrimidinesMolecular StructureCell ProliferationDrug Design

Stichwörter der Autor:innen

DHFRGluNCITSpyrazolo[34-d]pyrimidine

Substanzen

PyrimidinesAntineoplastic AgentsFolic Acid Antagonists

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Bisha, Bisha, Saudi Arabia.
  • Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.

Förderung

  • Najran University

Zitieren

APA

Mahnashi, M., Alshahrani, M. M., Al Ali, A., Asiri, A., & Abou-Salim, M. A. (2023). Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 38(1). https://doi.org/10.1080/14756366.2023.2203879

Vancouver

Mahnashi M, Alshahrani MM, Al Ali A, Asiri A, Abou-Salim MA. Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2023;38(1). doi:10.1080/14756366.2023.2203879

BibTeX
@article{Mahnashi2023,
  author = {Mahnashi, Mater and Alshahrani, Mohammed Merae and Al Ali, Amer and Asiri, Abdulaziz and Abou-Salim, Mahrous A},
  title = {Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2023},
  volume = {38},
  number = {1},
  doi = {10.1080/14756366.2023.2203879}
}
Kostenlos starten →